T1	Treatment 40 48	dialysis
T2	Treatment 195 203	dialysis
T3	Treatment 552 565	hemodialysis.
T4	Treatment 566 637	C-terminal FGF23 concentrations were measured in stored plasma samples.
T5	Treatment 638 882	Linear regression was used to examine the cross-sectional associations of plasma FGF23 concentrations with BMI, total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C) and triglycerides.
T6	Treatment 1710 1734	dyslipidemia in dialysis
